Cell therapy has the potential to reduce the risk of infection after stem cell transplants. The U.S. Food and Drug Administration (FDA) recently approved Omisirge (omidubicel-onlv), a donor-modified…
Read MoreBlood Donation
FDA Study Reconsiders Blood Donation Restrictions
Blood shortage prompts reassessment of LGBTQ donation ban. The American Red Cross has seen a 10 percent drop in blood donations since the start of the pandemic, leading…
Read More